Eledon Pharmaceuticals Balance Sheet Health
Financial Health criteria checks 6/6
Eledon Pharmaceuticals has a total shareholder equity of $76.1M and total debt of $0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are $114.6M and $38.5M respectively.
Key information
0%
Debt to equity ratio
US$0
Debt
| Interest coverage ratio | n/a |
| Cash | US$78.19m |
| Equity | US$76.06m |
| Total liabilities | US$38.52m |
| Total assets | US$114.58m |
Recent financial health updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 2TK's short term assets ($81.5M) exceed its short term liabilities ($12.5M).
Long Term Liabilities: 2TK's short term assets ($81.5M) exceed its long term liabilities ($26.0M).
Debt to Equity History and Analysis
Debt Level: 2TK is debt free.
Reducing Debt: 2TK had no debt 5 years ago.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: 2TK has sufficient cash runway for more than a year based on its current free cash flow.
Forecast Cash Runway: 2TK is forecast to have sufficient cash runway for 11 months based on free cash flow estimates, but has since raised additional capital.